MedTrace Logo

Writing About Disease: Effect on Rehabilitation?

NCT00251420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2009-05-07

No results posted yet for this study

Summary

Therapeutic writing about one's emotions has been described previously (J Pennebaker: Emotions, disclosure and health. Am Psychol. Assoc 1995). The present project will compare the effects (if any) of writing about the emotional versus the physical consequences of lung disease on anxiety, perceived quality of life, and perceived health status.

Conditions

Interventions

PROCEDURE

writing about disease

writing about physical or emotional consequences of pulmonary disease

Sponsors & Collaborators

  • The norwegian association for heart and lung patients

    collaborator UNKNOWN

  • LHL Helse

    lead OTHER

Principal Investigators

  • Einar Haave, Cand Psychol · LHL Helse

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2007-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00251420 on ClinicalTrials.gov